应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBIO BridgeBio Pharma, Inc.
休市中 07-11 16:00:00 EDT
46.47
+0.20
+0.43%
盘后
46.47
+0.00
0.00%
19:14 EDT
最高
46.76
最低
45.73
成交量
218.80万
今开
45.98
昨收
46.27
日振幅
2.23%
总市值
88.24亿
流通市值
69.10亿
总股本
1.90亿
成交额
1.01亿
换手率
1.47%
流通股本
1.49亿
市净率
-5.35
ROE
-1789.67%
每股收益
-3.54
52周最高
46.80
52周最低
21.72
市盈率
-13.14
股息
0.00
股息收益率
0.00
ROA
-48.27%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Bridgebio Pharma, Inc.7月10日成交额为1.12亿美元
市场透视 · 07-11 01:21
Bridgebio Pharma, Inc.7月10日成交额为1.12亿美元
Bridgebio Pharma, Inc.盘中异动 股价大涨5.04%
市场透视 · 07-09
Bridgebio Pharma, Inc.盘中异动 股价大涨5.04%
Bridgebio Pharma, Inc.7月1日成交额为1.18亿美元
市场透视 · 07-02
Bridgebio Pharma, Inc.7月1日成交额为1.18亿美元
Bridgebio Pharma, Inc.6月30日成交额为2.37亿美元
市场透视 · 07-01
Bridgebio Pharma, Inc.6月30日成交额为2.37亿美元
Bridgebio Pharma, Inc.6月27日成交额为3.79亿美元
市场透视 · 06-28
Bridgebio Pharma, Inc.6月27日成交额为3.79亿美元
Bridgebio Pharma, Inc.6月25日成交额为1.42亿美元
市场透视 · 06-26
Bridgebio Pharma, Inc.6月25日成交额为1.42亿美元
Bridgebio Pharma, Inc.6月24日成交额为1.68亿美元
市场透视 · 06-25
Bridgebio Pharma, Inc.6月24日成交额为1.68亿美元
Bridgebio Pharma, Inc.6月23日成交额为1.09亿美元
市场透视 · 06-24
Bridgebio Pharma, Inc.6月23日成交额为1.09亿美元
Bridgebio Pharma, Inc.6月20日成交额为2.29亿美元
市场透视 · 06-21
Bridgebio Pharma, Inc.6月20日成交额为2.29亿美元
Bridgebio Pharma, Inc.6月17日成交额为1.48亿美元
市场透视 · 06-18
Bridgebio Pharma, Inc.6月17日成交额为1.48亿美元
Bridgebio Pharma, Inc.6月16日成交额为1.17亿美元
市场透视 · 06-17
Bridgebio Pharma, Inc.6月16日成交额为1.17亿美元
Bridgebio Pharma, Inc.6月13日成交额为1.04亿美元
市场透视 · 06-14
Bridgebio Pharma, Inc.6月13日成交额为1.04亿美元
Bridgebio Pharma, Inc.6月11日成交额为8836.17万美元
市场透视 · 06-12
Bridgebio Pharma, Inc.6月11日成交额为8836.17万美元
Bridgebio Pharma, Inc.6月10日成交额为1.08亿美元
市场透视 · 06-11
Bridgebio Pharma, Inc.6月10日成交额为1.08亿美元
Bridgebio Pharma, Inc.6月9日成交额为1.15亿美元
市场透视 · 06-10
Bridgebio Pharma, Inc.6月9日成交额为1.15亿美元
HC Wainwright & Co.:维持BridgeBio Pharma(BBIO.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至56.00美元。
金融界 · 06-09
HC Wainwright & Co.:维持BridgeBio Pharma(BBIO.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至56.00美元。
Bridgebio Pharma, Inc.6月6日成交额为1.04亿美元
市场透视 · 06-07
Bridgebio Pharma, Inc.6月6日成交额为1.04亿美元
Bridgebio Pharma, Inc.6月4日成交额为1.34亿美元
市场透视 · 06-05
Bridgebio Pharma, Inc.6月4日成交额为1.34亿美元
Bridgebio Pharma, Inc.6月3日成交额为1.14亿美元
市场透视 · 06-04
Bridgebio Pharma, Inc.6月3日成交额为1.14亿美元
Bridgebio Pharma, Inc.6月2日成交额为8202.43万美元
市场透视 · 06-03
Bridgebio Pharma, Inc.6月2日成交额为8202.43万美元
加载更多
公司概况
公司名称:
BridgeBio Pharma, Inc.
所属市场:
NASDAQ
上市日期:
2019-06-27
主营业务:
BridgeBio Pharma, Inc.于2019年5月17日在特拉华州成立。该公司是一家处于商业阶段的生物制药公司,旨在发现、创造、测试和提供具有变革性的药物,以治疗具有明确遗传驱动因素的遗传性疾病和癌症患者。
发行价格:
17.00
{"stockData":{"symbol":"BBIO","market":"US","secType":"STK","nameCN":"BridgeBio Pharma, Inc.","latestPrice":46.47,"timestamp":1752264000000,"preClose":46.27,"halted":0,"volume":2187980,"hourTrading":{"tag":"盘后","latestPrice":46.47,"preClose":46.47,"latestTime":"19:14 EDT","volume":93328,"amount":4336960.55,"timestamp":1752275649417},"delay":0,"floatShares":148704782,"shares":189880720,"eps":-3.535422,"marketStatus":"休市中","change":0.2,"latestTime":"07-11 16:00:00 EDT","open":45.98,"high":46.76,"low":45.7291,"amount":101328344.76866,"amplitude":0.02228,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.535422,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1561608000000,"exchange":"NASDAQ","adjPreClose":46.27,"preHourTrading":{"tag":"盘前","latestPrice":46.04,"preClose":46.27,"latestTime":"09:23 EDT","volume":756,"amount":34545.56364,"timestamp":1752240185002},"postHourTrading":{"tag":"盘后","latestPrice":46.47,"preClose":46.47,"latestTime":"19:14 EDT","volume":93328,"amount":4336960.55,"timestamp":1752275649417},"volumeRatio":0.7777284170132553,"impliedVol":0.5497,"impliedVolPercentile":0.288},"requestUrl":"/m/hq/s/BBIO","defaultTab":"news","newsList":[{"id":"2550160840","title":"Bridgebio Pharma, Inc.7月10日成交额为1.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550160840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550160840?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:21","pubTimestamp":1752196867,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,Bridgebio Pharma, Inc.成交额为1.12亿美元,成交额较昨日减少46.88%,当日成交量为242.49万股。Bridgebio Pharma, Inc.于2025年7月10日涨0.63%,报46.27美元,该股过去5个交易日涨8.03%,年初至今涨68.62%,过去60日涨36.45%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-10|1.12亿|-46.88%|242.49万|#|2025-07-09|2.11亿|142.43%|463.40万|#|2025-07-08|8719.74万|-20.89%|200.71万|#|2025-07-07|1.10亿|2.60%|254.08万|#|2025-07-03|1.07亿|-4.87%|245.97万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092116a6a29121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092116a6a29121&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BBIO","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2550659329","title":"Bridgebio Pharma, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659329?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:51","pubTimestamp":1752072714,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时51分,Bridgebio Pharma, Inc.股票出现波动,股价快速上涨5.04%。Bridgebio Pharma, Inc.股票所在的生物技术行业中,整体涨幅为1.09%。其相关个股中,Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃,换手率分别为1121.58%、712.29%、532.86%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Prokidney Corp.,振幅分别为173.13%、112.02%、56.84%。Bridgebio Pharma, Inc.公司简介:BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225155a69fabf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225155a69fabf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBIO","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2548834160","title":"Bridgebio Pharma, Inc.7月1日成交额为1.18亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548834160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548834160?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:19","pubTimestamp":1751419188,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,Bridgebio Pharma, Inc.成交额为1.18亿美元,成交额较昨日减少50.18%,当日成交量为278.22万股。Bridgebio Pharma, Inc.于2025年7月1日跌0.93%,报42.78美元,该股过去5个交易日跌3.76%,年初至今涨55.9%,过去60日涨25.57%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-01|1.18亿|-50.18%|278.22万|#|2025-06-30|2.37亿|-37.45%|546.87万|#|2025-06-27|3.79亿|228.11%|845.32万|#|2025-06-26|1.16亿|-18.35%|258.75万|#|2025-06-25|1.42亿|-15.49%|318.59万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092000a7295f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702092000a7295f0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BBIO","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2548042211","title":"Bridgebio Pharma, Inc.6月30日成交额为2.37亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548042211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548042211?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:19","pubTimestamp":1751332767,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日,Bridgebio Pharma, Inc.成交额为2.37亿美元,成交额较昨日减少37.45%,当日成交量为546.87万股。Bridgebio Pharma, Inc.于2025年6月30日跌3.74%,报43.18美元,该股过去5个交易日涨2.37%,年初至今涨57.36%,过去60日涨24.73%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-30|2.37亿|-37.45%|546.87万|#|2025-06-27|3.79亿|228.11%|845.32万|#|2025-06-26|1.16亿|-18.35%|258.75万|#|2025-06-25|1.42亿|-15.49%|318.59万|#|2025-06-24|1.68亿|54.22%|381.56万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091937a7272b7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091937a7272b7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","BK4139","BBIO","BK4588"],"gpt_icon":0},{"id":"2546778832","title":"Bridgebio Pharma, Inc.6月27日成交额为3.79亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546778832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546778832?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:19","pubTimestamp":1751073573,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,Bridgebio Pharma, Inc.成交额为3.79亿美元,成交额较昨日增加228.11%,当日成交量为845.32万股。Bridgebio Pharma, Inc.于2025年6月27日跌0.58%,报44.86美元,该股过去5个交易日涨7.5%,年初至今涨63.48%,过去60日涨35.86%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-27|3.79亿|228.11%|845.32万|#|2025-06-26|1.16亿|-18.35%|258.75万|#|2025-06-25|1.42亿|-15.49%|318.59万|#|2025-06-24|1.68亿|54.22%|381.56万|#|2025-06-23|1.09亿|-52.55%|258.97万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628091936a4c230e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628091936a4c230e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4505","BK4585","BK4139","BBIO"],"gpt_icon":0},{"id":"2546107278","title":"Bridgebio Pharma, Inc.6月25日成交额为1.42亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546107278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546107278?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:19","pubTimestamp":1750900794,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,Bridgebio Pharma, Inc.成交额为1.42亿美元,成交额较昨日减少15.49%,当日成交量为318.59万股。Bridgebio Pharma, Inc.于2025年6月25日跌0.16%,报44.38美元,该股过去5个交易日涨10.76%,年初至今涨61.73%,过去60日涨26.4%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-25|1.42亿|-15.49%|318.59万|#|2025-06-24|1.68亿|54.22%|381.56万|#|2025-06-23|1.09亿|-52.55%|258.97万|#|2025-06-20|2.29亿|73.67%|552.60万|#|2025-06-18|1.32亿|-11.10%|325.96万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626092004a4be34d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626092004a4be34d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BBIO","BK4505","BK4139"],"gpt_icon":0},{"id":"2546257071","title":"Bridgebio Pharma, Inc.6月24日成交额为1.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546257071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546257071?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:19","pubTimestamp":1750814377,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Bridgebio Pharma, Inc.成交额为1.68亿美元,成交额较昨日增加54.22%,当日成交量为381.56万股。Bridgebio Pharma, Inc.于2025年6月24日涨5.39%,报44.45美元,该股过去5个交易日涨8.05%,年初至今涨61.99%,过去60日涨22.12%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-24|1.68亿|54.22%|381.56万|#|2025-06-23|1.09亿|-52.55%|258.97万|#|2025-06-20|2.29亿|73.67%|552.60万|#|2025-06-18|1.32亿|-11.10%|325.96万|#|2025-06-17|1.48亿|26.94%|368.06万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091944a71c1135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091944a71c1135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BBIO","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"2545424135","title":"Bridgebio Pharma, Inc.6月23日成交额为1.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545424135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545424135?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:19","pubTimestamp":1750727971,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,Bridgebio Pharma, Inc.成交额为1.09亿美元,成交额较昨日减少52.55%,当日成交量为258.97万股。Bridgebio Pharma, Inc.于2025年6月23日涨1.07%,报42.18美元,该股过去5个交易日涨6.02%,年初至今涨53.7%,过去60日涨16.83%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-23|1.09亿|-52.55%|258.97万|#|2025-06-20|2.29亿|73.67%|552.60万|#|2025-06-18|1.32亿|-11.10%|325.96万|#|2025-06-17|1.48亿|26.94%|368.06万|#|2025-06-16|1.17亿|11.95%|286.48万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624091934a71a403b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624091934a71a403b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","BK4585","BBIO","BK4139"],"gpt_icon":0},{"id":"2545099091","title":"Bridgebio Pharma, Inc.6月20日成交额为2.29亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545099091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545099091?lang=zh_cn&edition=full","pubTime":"2025-06-21 09:19","pubTimestamp":1750468798,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,Bridgebio Pharma, Inc.成交额为2.29亿美元,成交额较昨日增加73.67%,当日成交量为552.60万股。Bridgebio Pharma, Inc.于2025年6月20日涨4.32%,报41.73美元,该股过去5个交易日涨5.25%,年初至今涨52.08%,过去60日涨13.58%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-20|2.29亿|73.67%|552.60万|#|2025-06-18|1.32亿|-11.10%|325.96万|#|2025-06-17|1.48亿|26.94%|368.06万|#|2025-06-16|1.17亿|11.95%|286.48万|#|2025-06-13|1.04亿|51.82%|264.48万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621092007a7156bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621092007a7156bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BBIO","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2544191229","title":"Bridgebio Pharma, Inc.6月17日成交额为1.48亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544191229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544191229?lang=zh_cn&edition=full","pubTime":"2025-06-18 09:19","pubTimestamp":1750209598,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,Bridgebio Pharma, Inc.成交额为1.48亿美元,成交额较昨日增加26.94%,当日成交量为368.06万股。Bridgebio Pharma, Inc.于2025年6月17日跌2.6%,报40.07美元,该股过去5个交易日跌0.05%,年初至今涨46.03%,过去60日涨15.24%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-17|1.48亿|26.94%|368.06万|#|2025-06-16|1.17亿|11.95%|286.48万|#|2025-06-13|1.04亿|51.82%|264.48万|#|2025-06-12|6874.85万|-22.20%|173.88万|#|2025-06-11|8836.17万|-18.50%|223.19万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618092013a4af7176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618092013a4af7176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BBIO","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2544987918","title":"Bridgebio Pharma, Inc.6月16日成交额为1.17亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544987918?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:19","pubTimestamp":1750123197,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,Bridgebio Pharma, Inc.成交额为1.17亿美元,成交额较昨日增加11.95%,当日成交量为286.48万股。Bridgebio Pharma, Inc.于2025年6月16日涨3.42%,报41.14美元,该股过去5个交易日涨5.41%,年初至今涨49.93%,过去60日涨21.32%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-16|1.17亿|11.95%|286.48万|#|2025-06-13|1.04亿|51.82%|264.48万|#|2025-06-12|6874.85万|-22.20%|173.88万|#|2025-06-11|8836.17万|-18.50%|223.19万|#|2025-06-10|1.08亿|-5.73%|270.88万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092007a4ad2c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617092007a4ad2c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","BK4585","BK4139","BBIO"],"gpt_icon":0},{"id":"2543651371","title":"Bridgebio Pharma, Inc.6月13日成交额为1.04亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651371?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:20","pubTimestamp":1749864008,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日,Bridgebio Pharma, Inc.成交额为1.04亿美元,成交额较昨日增加51.82%,当日成交量为264.48万股。Bridgebio Pharma, Inc.于2025年6月13日涨0.33%,报39.78美元,该股过去5个交易日涨3.0%,年初至今涨44.97%,过去60日涨17.87%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-13|1.04亿|51.82%|264.48万|#|2025-06-12|6874.85万|-22.20%|173.88万|#|2025-06-11|8836.17万|-18.50%|223.19万|#|2025-06-10|1.08亿|-5.73%|270.88万|#|2025-06-09|1.15亿|10.14%|292.30万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092021a4a8750d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614092021a4a8750d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BBIO","BK4588","BK4505"],"gpt_icon":0},{"id":"2542333554","title":"Bridgebio Pharma, Inc.6月11日成交额为8836.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333554?lang=zh_cn&edition=full","pubTime":"2025-06-12 09:20","pubTimestamp":1749691220,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日,Bridgebio Pharma, Inc.成交额为8836.17万美元,成交额较昨日减少18.50%,当日成交量为223.19万股。Bridgebio Pharma, Inc.于2025年6月11日跌2.59%,报39.05美元,该股过去5个交易日涨2.71%,年初至今涨42.31%,过去60日涨18.3%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-11|8836.17万|-18.50%|223.19万|#|2025-06-10|1.08亿|-5.73%|270.88万|#|2025-06-09|1.15亿|10.14%|292.30万|#|2025-06-06|1.04亿|20.64%|268.25万|#|2025-06-05|8655.00万|-35.35%|226.11万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092031a4a42f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092031a4a42f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BBIO","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2542832406","title":"Bridgebio Pharma, Inc.6月10日成交额为1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542832406","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542832406?lang=zh_cn&edition=full","pubTime":"2025-06-11 09:19","pubTimestamp":1749604780,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日,Bridgebio Pharma, Inc.成交额为1.08亿美元,成交额较昨日减少5.73%,当日成交量为270.88万股。Bridgebio Pharma, Inc.于2025年6月10日涨2.72%,报40.09美元,该股过去5个交易日涨6.85%,年初至今涨46.1%,过去60日涨21.6%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-10|1.08亿|-5.73%|270.88万|#|2025-06-09|1.15亿|10.14%|292.30万|#|2025-06-06|1.04亿|20.64%|268.25万|#|2025-06-05|8655.00万|-35.35%|226.11万|#|2025-06-04|1.34亿|17.11%|350.32万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611091943a4a2ac2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611091943a4a2ac2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4588","BK4585","BBIO"],"gpt_icon":0},{"id":"2542354582","title":"Bridgebio Pharma, Inc.6月9日成交额为1.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542354582?lang=zh_cn&edition=full","pubTime":"2025-06-10 09:19","pubTimestamp":1749518366,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日,Bridgebio Pharma, Inc.成交额为1.15亿美元,成交额较昨日增加10.14%,当日成交量为292.30万股。Bridgebio Pharma, Inc.于2025年6月9日涨1.06%,报39.03美元,该股过去5个交易日涨10.07%,年初至今涨42.24%,过去60日涨20.8%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-09|1.15亿|10.14%|292.30万|#|2025-06-06|1.04亿|20.64%|268.25万|#|2025-06-05|8655.00万|-35.35%|226.11万|#|2025-06-04|1.34亿|17.11%|350.32万|#|2025-06-03|1.14亿|39.36%|307.99万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610091928a70153c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610091928a70153c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BBIO","BK4585","BK4139","BK4505"],"gpt_icon":0},{"id":"2542838161","title":"HC Wainwright & Co.:维持BridgeBio Pharma(BBIO.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至56.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542838161","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542838161?lang=zh_cn&edition=full","pubTime":"2025-06-09 19:42","pubTimestamp":1749469324,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持BridgeBio Pharma(BBIO.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至56.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09194250954533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBIO"],"gpt_icon":0},{"id":"2541689428","title":"Bridgebio Pharma, Inc.6月6日成交额为1.04亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541689428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541689428?lang=zh_cn&edition=full","pubTime":"2025-06-07 09:19","pubTimestamp":1749259150,"startTime":"0","endTime":"0","summary":"美东时间2025年6月6日,Bridgebio Pharma, Inc.成交额为1.04亿美元,成交额较昨日增加20.64%,当日成交量为268.25万股。Bridgebio Pharma, Inc.于2025年6月6日涨0.73%,报38.62美元,该股过去5个交易日涨12.76%,年初至今涨40.74%,过去60日涨18.5%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-06|1.04亿|20.64%|268.25万|#|2025-06-05|8655.00万|-35.35%|226.11万|#|2025-06-04|1.34亿|17.11%|350.32万|#|2025-06-03|1.14亿|39.36%|307.99万|#|2025-06-02|8202.43万|-18.63%|232.87万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607091914a49d80bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607091914a49d80bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","BK4505","BBIO"],"gpt_icon":0},{"id":"2541013207","title":"Bridgebio Pharma, Inc.6月4日成交额为1.34亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541013207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541013207?lang=zh_cn&edition=full","pubTime":"2025-06-05 09:19","pubTimestamp":1749086354,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日,Bridgebio Pharma, Inc.成交额为1.34亿美元,成交额较昨日增加17.11%,当日成交量为350.32万股。Bridgebio Pharma, Inc.于2025年6月4日涨1.33%,报38.02美元,该股过去5个交易日涨17.85%,年初至今涨38.56%,过去60日涨21.08%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-04|1.34亿|17.11%|350.32万|#|2025-06-03|1.14亿|39.36%|307.99万|#|2025-06-02|8202.43万|-18.63%|232.87万|#|2025-05-30|1.01亿|16.18%|296.51万|#|2025-05-29|8676.81万|7.29%|262.33万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605091928a6faf424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605091928a6faf424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4588","BBIO","BK4139","BK4585"],"gpt_icon":0},{"id":"2540896420","title":"Bridgebio Pharma, Inc.6月3日成交额为1.14亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540896420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540896420?lang=zh_cn&edition=full","pubTime":"2025-06-04 09:19","pubTimestamp":1748999948,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日,Bridgebio Pharma, Inc.成交额为1.14亿美元,成交额较昨日增加39.36%,当日成交量为307.99万股。Bridgebio Pharma, Inc.于2025年6月3日涨5.81%,报37.52美元,该股过去5个交易日涨13.35%,年初至今涨36.73%,过去60日涨18.85%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-03|1.14亿|39.36%|307.99万|#|2025-06-02|8202.43万|-18.63%|232.87万|#|2025-05-30|1.01亿|16.18%|296.51万|#|2025-05-29|8676.81万|7.29%|262.33万|#|2025-05-28|8087.34万|54.68%|247.52万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604091917a6f96831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604091917a6f96831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","BK4505","BBIO"],"gpt_icon":0},{"id":"2540712288","title":"Bridgebio Pharma, Inc.6月2日成交额为8202.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540712288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540712288?lang=zh_cn&edition=full","pubTime":"2025-06-03 09:19","pubTimestamp":1748913545,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日,Bridgebio Pharma, Inc.成交额为8202.43万美元,成交额较昨日减少18.63%,当日成交量为232.87万股。Bridgebio Pharma, Inc.于2025年6月2日涨3.53%,报35.46美元,该股过去5个交易日涨6.36%,年初至今涨29.23%,过去60日涨10.02%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-02|8202.43万|-18.63%|232.87万|#|2025-05-30|1.01亿|16.18%|296.51万|#|2025-05-29|8676.81万|7.29%|262.33万|#|2025-05-28|8087.34万|54.68%|247.52万|#|2025-05-27|5228.55万|-22.91%|157.35万|BridgeBio Pharma是一家生物技术公司,专注于发现、开发、测试和提供针对遗传疾病患者的变革性治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603091910a4976759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603091910a4976759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","BBIO","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bridgebio.com;investor.bridgebio.com","stockEarnings":[{"period":"1week","weight":0.0564},{"period":"1month","weight":0.19},{"period":"3month","weight":0.3704},{"period":"6month","weight":0.598},{"period":"1year","weight":0.7282},{"period":"ytd","weight":0.6935}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BridgeBio Pharma, Inc.于2019年5月17日在特拉华州成立。该公司是一家处于商业阶段的生物制药公司,旨在发现、创造、测试和提供具有变革性的药物,以治疗具有明确遗传驱动因素的遗传性疾病和癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.052015},{"month":2,"riseRate":0.5,"avgChangeRate":0.034422},{"month":3,"riseRate":0.333333,"avgChangeRate":0.071713},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.072554},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032997},{"month":6,"riseRate":0.833333,"avgChangeRate":0.148281},{"month":7,"riseRate":0.571429,"avgChangeRate":0.131122},{"month":8,"riseRate":0.666667,"avgChangeRate":0.029525},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.060206},{"month":10,"riseRate":0.666667,"avgChangeRate":0.014306},{"month":11,"riseRate":0.666667,"avgChangeRate":0.094984},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044694}],"exchange":"NASDAQ","name":"BridgeBio Pharma, Inc.","nameEN":"BridgeBio Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BridgeBio Pharma, Inc.(BBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BridgeBio Pharma, Inc.(BBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BridgeBio Pharma, Inc.,BBIO,BridgeBio Pharma, Inc.股票,BridgeBio Pharma, Inc.股票老虎,BridgeBio Pharma, Inc.股票老虎国际,BridgeBio Pharma, Inc.行情,BridgeBio Pharma, Inc.股票行情,BridgeBio Pharma, Inc.股价,BridgeBio Pharma, Inc.股市,BridgeBio Pharma, Inc.股票价格,BridgeBio Pharma, Inc.股票交易,BridgeBio Pharma, Inc.股票购买,BridgeBio Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BridgeBio Pharma, Inc.(BBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BridgeBio Pharma, Inc.(BBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}